Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocol.
Saved in:
| Title: | Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with treatment-refractory OUD: A randomized, double-blind, placebo-controlled clinical trial protocol. |
|---|---|
| Authors: | Freet CS; Penn State College of Medicine., Shuler K; Penn State College of Medicine., Kawasaki S; Penn State College of Medicine., Weintraub E; University of Maryland School of Medicine., Greenblatt A; University of Maryland School of Medicine., Kladney M; New York University Grossman School of Medicine., Nunes E; Columbia University Irving Medical Center., Foster KL; National Institute on Drug Abuse., Kong L; Penn State College of Medicine., Raja-Khan N; Penn State College of Medicine., Cleveland HH; Pennsylvania State University., Grigson PS; Penn State College of Medicine., Bunce SC; Penn State College of Medicine., Brick TR; Pennsylvania State University., Nyland JE; Penn State College of Medicine. |
| Source: | Research square [Res Sq] 2025 May 26. Date of Electronic Publication: 2025 May 26. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet ISSN: 2693-5015 (Electronic) Linking ISSN: 26935015 NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
